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Abstract 
Electronic cigarettes (e-cigarettes) are battery operated devices that deliver nicotine via inhaled 
vapour.  Few studies have evaluated acute effects on craving and mood, and none have explored 
effects on cognition.  This study aimed to explore the effects of the White Super e-cigarette on 
desire to smoke, nicotine withdrawal symptoms, attention and working memory.  Eighty-six smokers 
were randomly allocated to either: 18mg nicotine e-cigarette (nicotine), 0mg e-cigarette (placebo), 
or just hold the e-cigarette (just hold) conditions.  Participants rated their desire to smoke and 
withdrawal symptoms at baseline (T1), and five (T2) and twenty (T3) minutes after using the e-
cigarette ad libitum for five minutes.  A subset of participants completed the Letter Cancellation and 
Brown-Peterson Working Memory Tasks.  After 20 minutes, compared with the just hold group, 
desire to smoke and some aspects of nicotine withdrawal were significantly reduced in the nicotine 
and placebo group; the nicotine e-cigarette was superior to placebo in males but not in females.  The 
nicotine e-cigarette also improved working memory performance compared with placebo at the 
longer interference intervals.   There was no effect of nicotine on Letter Cancellation performance.  
To conclude, the White Super e-cigarette alleviated desire to smoke and withdrawal symptoms 20 
minutes after use although the nicotine content was more important for males.  This study also 
demonstrated for the first time that the nicotine e-cigarette can enhance working memory 
performance.  Further evaluation of the cognitive effects of the e-cigarette and its efficacy as a 
cessation tool is merited. 
Key Words: 
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1. Introduction 
Electronic cigarettes (e-cigarettes) are battery-operated devices that deliver nicotine via  inhaled 
vapour.   Since no tobacco is burned, inhaling nicotine in this way potentially provides a safer 
alternative to smoking since it eliminates the harmful tars and carbon monoxide.  E-cigarettes may 
therefore have a role to play in smoking cessation/ reduction.  Although their efficacy in this respect 
has not been empirically explored,  quit rates in the region of 22-49% are indicated in two recent 
studies (Polosa et al., 2011; Seigel, Tanwar & Wood, 2011). 
 Any possible effect on smoking cessation/reduction, however, is unlikely to occur unless e-
cigarettes are satisfying to use, and can effectively reduce desire to smoke and withdrawal 
symptoms.   Bullen et al. (2010) reported significant and comparable reductions in desire to smoke 
with the 16mg Ruyan e-cigarette and nicotine inhalator but both were less effective than regular 
smoking.    A second study also reported  reduced desire to smoke and some withdrawal symptoms 
although both e-cigarette brands tested failed to raise blood nicotine levels and heart rate over a 45 
minute period  (Vansickel, Cobb, Weaver, & Eissenberg, 2010). 
That desire to smoke and withdrawal symptoms were reduced in the absence of raised blood 
nicotine levels is consistent with the notion that other sensorimotor factors contribute to its 
reinforcing effects.  Several studies have demonstrated preference for smoking, reduced desire to 
smoke and withdrawal symptoms following the use of denicotinised tobacco (DT) (e.g. Rose, Behm, 
Westman & Johnson, 2010) particularly in females (Barrett, 2010). 
In addition to the putative reinforcing effects of sensorimotor aspects of smoking, smokers often  
report that it aids concentration and cognition (McEwen, West & McRobbie, 2008; Hughes & 
Hatsukami, 1986) and there is empirical evidence to support this assertion (see review by Heishman, 
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Kleykamp & Singleton, 2010).  Nevertheless, whether nicotine derived via e-cigarettes can impact on 
cognitive processes has not been explored.   
The present study aimed to explore whether the e-cigarette can reduce desire to smoke and 
abstinence-related withdrawal symptoms over a twenty minute period.  To determine whether the 
nicotine content itself rather than other sensory factors associated with smoking (e.g. visual cues, 
buccal sensations) are responsible for these effects, we compared the nicotine e-cigarette, placebo 
e-cigarette and a 'just hold’ group (to control for visual and tactile aspects of handing, but not using 
the e-cigarette).   It was hypothesised that after five minutes, desire to smoke and withdrawal 
symptoms would decline in both the nicotine and placebo conditions relative to the just hold 
condition (consistent with a sensorimotor explanation).  After 20 minutes however, when nicotine 
reaches peak plasma levels (Bullen et al., 2010), it was predicted that the nicotine group would show 
a further reduction in symptoms relative to the ‘just hold’ and placebo groups.  Given previous 
reports suggesting the importance of sensorimotor aspects of smoking in women (Barrett, 2010; 
Perkins, Donny & Caggiula, 1999) data were explored separately by gender.  We also included two 
short cognitive tests (to tap attention/speed of processing and working memory) to explore whether 
nicotine derived via the e-cigarette is capable of enhancing cognitive functioning.    
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2. Methods 
  
In this mixed experimental design, 86 e-cigarette naive smokers (43 female; age range: 18-52 [mean: 
28.8]) were randomly allocated to either  18mg nicotine e-cigarette (nicotine), 0mg e-cigarette 
(placebo; nicotine and placebo conditions administered single-blind) or just hold the e-cigarette (just 
hold) condition.  The ‘White Super’ electronic cigarette was used (devices and cartridges supplied by 
The Electronic Cigarette Company) with a new tobacco flavoured cartridge for each participant. 
 
Following abstinence from smoking for at least one hour, participants completed The Fagerstrom 
Test of Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström 1991),  a single-
item desire to smoke scale, and the Mood and Physical Symptoms Scale (MPSS; Hughes & 
Hatsukami, 1986; to assess six nicotine withdrawal symptoms: depression, irritability, anxiety, 
restlessness, hunger, poor concentration) at baseline (T1),  five (T2) and twenty (T3) minutes after 
using (or just holding) the electronic cigarette ad libitum for five minutes.  A subset of participants (N 
= 60; 29 females) also completed the Letter Cancellation Task and the Brown-Peterson Working 
Memory Task in the interval between T2 and T3.   
 
The letter cancellation task was presented first.  This provides a quick measure of attention/speed of 
processing and visual-spatial scanning ability (Eysenck & Keane, 2005). Participants are required to 
find a specific letter (e.g.  'u') and cross  through each occurrence of it in a 18 X 18cm grid where it is 
presented amongst similarly-formed letters (e.g. 'v' and 'o').   Time taken and number of errors are 
recorded.  In the Brown-Peterson Memory Task (Peterson & Peterson, 1959) participants are 
presented with a series of trigrams (consonants in sets of threes, e.g. TGH) and then asked to count 
backwards in threes from a specified number before recalling the trigram.  The interference interval 
(counting backwards in serial threes) increased over six consecutive trials (3, 6, 9, 12, 15 and 18 
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seconds). For each trial, responses were scored as correct (all three letters correctly recalled) or 
incorrect (< two letters correctly recalled). 
 
At the end of the testing procedure, participants were asked to indicate which cartridge they 
thought they had received (nicotine or placebo)  before being informed of their group allocation.  
The study was approved by the University of East London’s Ethical Committee.   
 
  
2.1 Statistical analysis 
The primary outcome measures of interest were change in desire to smoke and the six withdrawal 
symptoms between the three groups over time, thus univariate ANOVAs in SPSS were conducted on 
change scores from T1 to  T2  and T1 to T3 (T1 minus T2 and T1 minus T3) for males and females 
separately.  A priori contrasts explored the hypothesis that from T1 to T2 nicotine and placebo 
groups would differ from the just hold group but not from each other, and from T1 to T3, the 
nicotine group would differ from the just hold and placebo groups (Bullen et al., 2010).  These 
specific contrasts between the three groups are of particular interest here although the main 
omnibus effect of group is reported where appropriate.  
Letter cancellation time and errors were also analyzed using one-way ANOVA with Fisher's Least 
Significant Difference (LSD) post-hoc tests to clarify any group differences (p < 0.05).   
To compare the number of participants between groups correctly recalling all three letters on the 
Brown-Peterson task, six 3x2 Chi Square tests were conducted (for all interference intervals) 
followed up by a series of 12 2x2 Chi Square tests for significant effects with a corrected alpha level 
of 0.004 (0.05/12) as a result of multiple tests.  Since there was no a priori reason to suppose that 
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cognitive performance would be influenced by gender, letter cancellation or memory performance 
were not analyzed by gender. 
  
3. Results 
  
The three groups did not differ in age, gender, ethnicity  or nicotine dependence (p > 0.15 in all 
cases).  Mean FTND score was 5.2 (2.1).  Guessing whether participants had received nicotine or 
placebo was at chance level: (χ2 (2) = 1.11, p > 0.05). 
  
3.1 Desire to Smoke 
Desire to smoke declined over time for both nicotine and placebo groups relative to the just hold 
group (Figure 1).  This difference was statistically significant for males and females from T1 to T3 
(males: just hold vs. nicotine: p < 0.001; just hold vs. placebo: p < 0.05; females: just hold vs. 
nicotine: p < 0.05; just hold vs. placebo p < 0.01) but not from T1 to T2 (males: F (2,40) < 1, p > 0.05;  
females: F (2,40) = 1,44, p > 0.05).  The decline in desire to smoke was also significantly greater in 
the nicotine vs. placebo group for males (p < 0.05) but not  females (p > 0.05; see Figure 1). 
 
 
3.2 Mood and Physical Symptoms Scale (MPSS)  
From T1 to T2 (see Table 2), overall main effects of group were only apparent for anxiety (females: F 
(2, 40) = 3.66, p < 0.05; males: F (2, 38) = 3.05, p = 0.06).  Differences were significant for nicotine vs. 
just hold and placebo vs. just hold for males (p < 0.05) and for placebo vs. just hold for females (p = 
0.01). 
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From T1 to T3 there were overall significant group differences for males in change in MPSS: anxiety 
(F (2, 40) = 6.35, p < 0.01), poor concentration (F (2, 40) = 4.23, p < 0.05), irritability (F (2, 40) = 4.44, 
p < 0.05) and restlessness (F (2, 40) = 4.45, p < 0.05).  In all cases, the decline in symptoms in the 
nicotine group was significantly lower than the just hold (all ps < 0.01) and placebo (all ps < 0.05) 
groups. 
 
The pattern of change in withdrawal symptoms from T1 to T3 for females indicated overall group 
differences for depression (F (2, 40) = 4.80, p < 0.05) and a trend for poor concentration (F (2, 40) = 
2.98, p = 0.06).  This reflected a greater reduction in symptoms in both the nicotine and placebo 
groups relative to the just hold group (all p < 0.05). 
 
3.3 Letter Cancellation Task 
Whilst the nicotine group were fastest to complete this task (mean = 63.70, SD = 13.87), followed by 
the just hold (mean = 64.95, SD = 13.58) and placebo group (mean = 71.05 , SD = 13.93) these 
differences were not significant (F (2,57) = 2.00, p = 0.14).  There was a significant group difference 
in the number of errors made (F (2, 57) = 3.34, p < 0.05) reflecting worse performance in the just 
hold (mean = 1.25, SD = 1.48)  vs. placebo group (mean = 0.25, SD = 0.44).  
 
3.4  Brown-Peterson Memory Test 
The nicotine group performed consistently better across all trials and retained better memory 
performance at the longer time intervals with significant group differences at 6 seconds (χ2 = 7.06 
(2), p < 0.05), 12 seconds (χ2 = 6.06 (2), p < 0.05), 15 seconds (χ2 = 11.31 (2), p < 0.01) and 18 seconds 
(χ2 = 12.35 (2), p < 0.01).  Significantly more individuals in the nicotine group achieved correct recall 
compared with  placebo at the 15 and 18 second interval (χ2 (1) = 10.42, p < 0.004; χ2 (1) = 8.12, p < 
0.004 respectively), and with the just hold group at the 18 second interval (χ2 (1) = 10.00, p < 0.004). 
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4. Discussion 
Desire to smoke and some aspects of nicotine withdrawal were significantly reduced twenty (but not 
five) minutes after e-cigarette use; the nicotine e-cigarette was superior to placebo in this respect in 
males but not in females.  Nicotine derived via use of the electronic cigarette also improved working 
memory performance particularly at the longer interference intervals.   
 
The desire to smoke findings are consistent with Bullen et al. (2010) who reported that nicotine 
blood concentrations reached a peak level of 1.3ng/ml in 20 minutes.  In relation to withdrawal 
symptoms, for males, the reduction in MPSS ratings from T1 to T3 was significantly greater in the 
nicotine group for anxiety, poor concentration, irritability and restlessness.  By contrast, there were 
no significant reductions in MPSS scores with nicotine in females.  Females in both the nicotine and 
placebo groups did however, report improvements in depression and concentration from T1 to T3 
relative to the just hold group, although this difference partly reflects an  increased level of symptom 
reporting in the just hold group.  One limitation of the present study was that participants were only 
1-2 hours abstinent; reflected in the low MPSS scores.  This low symptom reporting at baseline (T1) 
would however, militate against finding an effect of e-cigarette use/nicotine on symptoms measured 
here due to floor-effects.  That significant findings still emerged (for males) is therefore all the more 
striking and suggests that a longer duration of abstinence may reveal more robust effects which may 
extend to females.    
 
The distinct and consistent findings for males and females across symptom reporting resonates with 
the emerging literature on sex differences in smoking reinforcement (Barrett, 2010; Perkins et al., 
1999) and the observation that, relative to females, males are more likely to succeed in quitting 
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using NRT (Perkins & Scott, 2008).  Thus one might tentatively conclude that the nicotine content 
may be more important for males and the sensorimotor aspects of smoking more important for 
females.  Cessation studies using the e-cigarette have yet to be completed but together these 
findings raise the intriguing possibility that females may be just as responsive to the placebo e-
cigarette for quitting.   
 
Performance on the letter cancellation task was not significantly influenced by e-cigarette use or the 
nicotine content specifically.  By contrast, nicotine was associated with superior working memory 
performance.  Recall  was consistently higher in the nicotine group with significant differences 
emerging relative to placebo and just hold groups at the longer interference periods (15 and 18 
seconds).  The Brown-Peterson task has, however, been criticised for lack of ecological validity and 
the categorical nature of scoring which lends itself to non-parametric testing.  Although this finding 
is consistent with a recent meta-analysis in which a significant positive effect of nicotine on working 
memory reaction time was observed (Heishman, Kleykamp and Singleton, 2010), it is clearly in need 
of replication.    
 
 
4.1 Conclusions 
Our findings suggest that the electronic cigarette can reduce desire to smoke and nicotine 
withdrawal symptoms twenty minutes after use and that the nicotine content may be more 
important for males.  This is also the first study to demonstrate that the nicotine e-cigarette can 
improve working memory performance.  Taken together these findings suggest that the electronic 
cigarette may aid smoking cessation and highlights the need for further research regarding the 
importance of the nicotine content and effects on a wider repertoire of cognitive functioning.   
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Table 1: Mean (SD) change scores1 for MPSS  variables from T1 to T2 and T1 to T3 for the three groups for males and females 
MPS    Nicotine Placebo  Just Hold 
Males 
 
T1-T2 T1-T3 T1-T2 T1-T3 T1-T2 T1-T3 
Anxiety 0.62 (1.04) * 0.62 (0.96) **# 0.13 (0.52) * 0.67 (0.46)  -0.15 (0.80) -0.31 (0.48) 
Poor concentration 0.08 (1.85) 0.69 (1.18) **# 0.07 (0.80) 0.07 (0.70)  0.08 (0.64) -0.23 (0.44) 
Depression 0.15 (0.38) 0.08 (0.28) 0.13 (0.35) 0.13 (0.35) -0.08 (0.28) -0.08 (0.28) 
Hunger -0.13 (1.32) -0.08 (0.76) 0.33 (0.62) -0.07 (0.59) 0.46 (1.05) 0.31 (0.75) 
Irritability -0.08 (1.50) 0.62 (0.77) **# 0.27 (0.88) 0.33 (0.90)  0.08 (0.49) -0.23 (0.44) 
Restlessness -0.08 (1.44) 0.62 (0.77) **# 0.13 (0.52) 0 (0.76)  0 (1.35) -0.23 (0.73) 
       
Females       
Anxiety 0.12 (0.60) 0.06 (0.83) 0.42 (0.79) * 0.33 (0.78) -0.36 (0.84) -0.14 (0.66) 
Poor concentration 0.29 (0.92) 0.24 (1.09) *  -0.17 (0.72) 0.25 (0.45) * -0.14 (0.66) -0.50 (1.02) 
Depression 0.12 (0.33) 0.12 (0.49) * 0.17 (0.58) 0.42 (0.67) * -0.07 (0.47) -0.29 (0.61) 
Hunger -0.18 (0.53) -0.18 (0.63) -0.17 (1.19) -0.08 (0.79) -0.14 (0.53) -0.29 (0.73) 
Irritability 0.06 (0.65) 0.06 (0.90) -0.08 (1.38) 0.17 (0.72) -0.07 (0.47) -0.07 (0.62) 
Restlessness 0.29 (0.99) 0.12 (1.36) 0 (1.48) 0.25 (0.97) 0.14 (0.66) -0.36 (1.15) 
 
1 A positive score reflects a decrease in symptom reporting over time whilst a negative score reflects an increase 
*Indicates significant difference from Just Hold (p < 0.05) 
** Indicates significant difference from Just Hold (p < 0.01) 
# Indicates significant difference from placebo (p < 0.05) 
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Legend for Figure: 
 
Figure 1: Mean (±1SE) desire to smoke scores in males and females for the nicotine e-cigarette, 
placebo e-cigarette and just hold groups over the three time points.  
 
 
